Literature DB >> 26445954

Association of serum adiponectin level with albuminuria in chronic kidney disease patients.

Ha Yeon Kim1, Eun Hui Bae1, Seong Kwon Ma1, Dong Wan Chae2, Kyu Hun Choi3, Yong-Soo Kim4, Young-Hwan Hwang5, Curie Ahn2, Soo Wan Kim6.   

Abstract

BACKGROUND: Adiponectin, a peptide hormone secreted from adipocytes, exerts anti-diabetic, anti-atherogenic, and anti-inflammatory properties. We aimed to determine the relationship between serum adiponectin levels and albuminuria, and evaluate determinant factors for serum adiponectin in patients with chronic kidney disease (CKD).
METHODS: In total, 1442 CKD patients were included and divided into three groups according to their albumin-to-creatinine ratios: patients with normoalbuminuria (N = 228), microalbuminuria (N = 444), and macroalbuminuria (N = 761). Serum adiponectin was specifically assayed with a commercially available enzyme-linked immunosorbent assay kit.
RESULTS: Serum adiponectin was significantly higher in patients with macroalbuminuria than in those without macroalbuminuria (9.7 ± 6.0, 12.4 ± 9.0, and 14.9 ± 11.0 μg/mL in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria, respectively). Univariate linear regression analysis showed that the serum adiponectin concentrations were correlated with age, the albumin-to-creatinine ratio, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, whereas they were negatively correlated with body mass index, the estimated glomerular filtration rate, and serum albumin and triglyceride levels. The stepwise regression multiple analysis showed that sex; the estimated glomerular filtration rate; body mass index; total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels; and logarithm of the albumin-to-creatinine ratio were independently associated with the logarithm of serum adiponectin levels (r = 0.55, p < 0.001).
CONCLUSION: Serum adiponectin concentrations are higher in patients with increasing albuminuria, and these levels are associated with renal insufficiency and lipid profiles.

Entities:  

Keywords:  Albuminuria; Chronic kidney disease; Serum adiponectin

Mesh:

Substances:

Year:  2015        PMID: 26445954     DOI: 10.1007/s10157-015-1173-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  34 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones.

Authors:  G A Laughlin; E Barrett-Connor; S May
Journal:  Int J Obes (Lond)       Date:  2006-07-04       Impact factor: 5.095

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 5.  Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.

Authors:  Karen R Rabin; Yehuda Kamari; Irit Avni; Ehud Grossman; Yehonatan Sharabi
Journal:  Expert Rev Cardiovasc Ther       Date:  2005-05

Review 6.  The role of adiponectin in renal physiology and development of albuminuria.

Authors:  Georgios A Christou; Dimitrios N Kiortsis
Journal:  J Endocrinol       Date:  2014-05-12       Impact factor: 4.286

7.  Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy.

Authors:  Jun Koshimura; Hiroki Fujita; Takuma Narita; Takashi Shimotomai; Mihoko Hosoba; Naomi Yoshioka; Masafumi Kakei; Hiromi Fujishima; Seiki Ito
Journal:  Biochem Biophys Res Commun       Date:  2004-03-26       Impact factor: 3.575

8.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

9.  Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.

Authors:  Koji Ohashi; Hirotsugu Iwatani; Shinji Kihara; Yasuhiko Nakagawa; Noriyuki Komura; Koichi Fujita; Norikazu Maeda; Makoto Nishida; Fumie Katsube; Iichiro Shimomura; Takahito Ito; Tohru Funahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-12       Impact factor: 8.311

10.  Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

Authors:  Hironori Waki; Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Shoko Uchida; Shunbun Kita; Kazuo Hara; Yusuke Hada; Francis Vasseur; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more
  9 in total

Review 1.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease.

Authors:  Qingzhang Zhu; Philipp E Scherer
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

2.  Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease.

Authors:  Nihal Aydemir; Mindy M Pike; Aseel Alsouqi; Samuel A E Headley; Katherine Tuttle; Elizabeth E Evans; Charles M Milch; Kelsey A Moody; Michael Germain; Loren Lipworth; Jonathan Himmelfarb; T A Ikizler; Cassianne Robinson-Cohen
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-04-21       Impact factor: 4.222

3.  Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Sue K Park; Ju Yeon Lee; Wookyung Chung; Kyubeck Lee; Yeong Hoon Kim; Kook-Hwan Oh; Curie Ahn; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2016-08-11       Impact factor: 2.801

Review 4.  The KNOW-CKD Study: What we have learned about chronic kidney diseases.

Authors:  Kook-Hwan Oh; Minjung Kang; Eunjeong Kang; Hyunjin Ryu; Seung Hyeok Han; Tae-Hyun Yoo; Soo Wan Kim; Dong-Wan Chae; Kyu-Beck Lee; Sue K Park; Yeong Hoon Kim; Curie Ahn
Journal:  Kidney Res Clin Pract       Date:  2020-06-30

5.  TGF-Beta Induced Key Genes of Osteogenic and Adipogenic Differentiation in Human Mesenchymal Stem Cells and MiRNA-mRNA Regulatory Networks.

Authors:  Genfa Du; Xinyuan Cheng; Zhen Zhang; Linjing Han; Keliang Wu; Yongjun Li; Xiaosheng Lin
Journal:  Front Genet       Date:  2021-11-25       Impact factor: 4.599

Review 6.  Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease.

Authors:  Sylwia Czaja-Stolc; Marta Potrykus; Marta Stankiewicz; Łukasz Kaska; Sylwia Małgorzewicz
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 5.717

7.  AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.

Authors:  Emma Börgeson; Ville Wallenius; Gulam H Syed; Manjula Darshi; Juan Lantero Rodriguez; Christina Biörserud; Malin Ragnmark Ek; Per Björklund; Marianne Quiding-Järbrink; Lars Fändriks; Catherine Godson; Kumar Sharma
Journal:  Diabetologia       Date:  2017-02-10       Impact factor: 10.122

8.  High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study.

Authors:  Su Hyun Song; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Seong Kwon Ma; Kook Hwan Oh; Curie Ahn; Soo Wan Kim; Eun Hui Bae
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

9.  Nutritional Status, Selected Nutrients Intake and Their Relationship with the Concentration of Ghrelin and Adiponectin in Patients with Diabetic Nephropathy.

Authors:  Iwona Boniecka; Anna Jeznach-Steinhagen; Weronika Michalska; Aleksandra Rymarz; Dorota Szostak-Węgierek; Stanisław Niemczyk
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.